A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

ABC News' Dr. Tara Narula shares what patients need to know. Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.

Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some ...

A study suggests that weight loss medications like Ozempic may help ... Eli Lilly says a new trial showed the key ingredient in its popular drugs Zepbound and Mounjaro helped slash the chance ...

The company's announcement came just after Lilly announced it is expanding the supply and cutting the costs of its weight-loss drug Zepbound, again, effectively broadening access to more patients ...